BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 27371544)

  • 1. Assessment of bleeding risk in low-weight patients receiving prophylactic subcutaneous unfractionated heparin.
    Jatis AJ; Nei SD; Zieminski JJ; Mara K; Krauter AK
    Vasc Med; 2023 Oct; 28(5):443-448. PubMed ID: 37555546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the safety and efficacy for different regimens of pharmaco-prophylaxis among severely burned patients: a randomized controlled trial.
    Al Sulaiman KA; Al-Ramahi G; Aljuhani O; Al-Joudi K; Alhujayri AK; Al-Shomer F; Silas J; Al Dabbagh T; Al Harbi S; AlDekhayel S; Eldali A; Alqahtani R; Vishwakarma R; Al-Dorzi HM
    Eur J Trauma Emerg Surg; 2024 Apr; 50(2):567-579. PubMed ID: 38240791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated With Continuous Low-Dose Heparin Infusion for Central Venous Catheter Patency in Critically Ill Children Worldwide.
    Onyeama SJ; Hanson SJ; Dasgupta M; Hoffmann RG; Faustino EV;
    Pediatr Crit Care Med; 2016 Aug; 17(8):e352-61. PubMed ID: 27362853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients.
    Wan T; Garland SJ; Drury CT; Lambert J; Yoon J; Chan M
    Thromb Res; 2024 Jul; 239():109036. PubMed ID: 38776611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia.
    Pang B; Kearney L; Maccarone J; Zhang J; Kearney C; Sangani R; Shankar DA; Gillmeyer KR; Law AC; Bosch NA
    Ann Am Thorac Soc; 2023 Jun; 20(6):917-920. PubMed ID: 36867519
    [No Abstract]   [Full Text] [Related]  

  • 6. Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations.
    Sebaaly J; Covert K
    Ann Pharmacother; 2018 Sep; 52(9):898-909. PubMed ID: 29592538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pattern of Heparin Dosing as Venous Thromboembolism Prophylaxis in Adult Underweight Patients Admitted to Critical Care Units at a Tertiary Hospital.
    Al Harthy N; Al Harthi F; Al Harb S; Al Dughayem N; Al Harthi K; Gramish J
    Cureus; 2022 Nov; 14(11):e31717. PubMed ID: 36569710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous Thromboembolism Prophylaxis in Underweight Hospitalized Patients.
    Buckheit D; Lefemine A; Sobieraj DM; Hobbs L
    Clin Appl Thromb Hemost; 2021; 27():10760296211018752. PubMed ID: 34080451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients.
    Dybdahl D; Walliser G; Pershing M; Collins C; Robinson D
    Clin Med Insights Blood Disord; 2019; 12():1179545X19863814. PubMed ID: 31360075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.
    Reynolds PM; Van Matre ET; Wright GC; McQueen RB; Burnham EL; Ho PJM; Moss M; Vandivier RW; Kiser TH;
    Pharmacotherapy; 2019 Mar; 39(3):232-241. PubMed ID: 30592541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
    Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
    J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis.
    Hamilton MG; Yee WH; Hull RD; Ghali WA
    Neurosurgery; 2011 Mar; 68(3):571-81. PubMed ID: 21311292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
    Lewis TC; Cortes J; Altshuler D; Papadopoulos J
    J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Experience With Pharmacological Venous Thromboembolism Prophylaxis in the Underweight and Critically Ill.
    Carter C; Bushwitz J; Gowan M; Pope H; Human T; Gibson G; Owen E; Hampton N; Whitman C
    Ann Pharmacother; 2016 Oct; 50(10):832-9. PubMed ID: 27371544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice Patterns of Venous Thromboembolism Prophylaxis in Underweight, Critically Ill Patients with Neurologic Injury.
    Betthauser K; Pope H; Gowan M; Human T
    Neurocrit Care; 2017 Aug; 27(1):96-102. PubMed ID: 28097621
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.